Most Read Articles
Jairia Dela Cruz, 3 days ago
Metabolic and bariatric surgery (MBS) leads to large and sustained reductions in, and even reversal of, multiple risk factors for future joint disease in adolescents with severe obesity and musculoskeletal pain, according to data from the Teen Longitudinal Assessment of Bariatric Surgery study.
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 6 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.

Faecal calprotectin levels tied to microscopic colitis risk

24 Dec 2019

High faecal calprotectin concentrations may be predictive of microscopic colitis in patients with chronic watery diarrhoea, a recent study has found.

Ninety-four patients underwent colonoscopy due to chronic water diarrhoea and were included in the analysis. Faecal samples were obtained 1–2 days before colonoscopy and subjected to enzyme-linked immunosorbent assays for the measurement of calprotectin levels. Thirty participants (mean age, 65.3±3.1 years; 80 percent female) had microscopic colitis; the remaining 64 (mean age, 52.2±1.9 years; 80 percent female) were designated as controls.

Researchers identified that the optimal cutoff for faecal calprotectin was >100 µg/g. At this threshold, the area under the curve was 0.73±0.06 (p<0.0001) for the prediction of microscopic colitis. The corresponding sensitivity and specificity values were 67 percent and 75 percent, respectively.

Similarly, this cutoff value yielded a positive and negative predictive values of 53 percent and 84 percent, respectively, for the diagnosis of microscopic colitis. When used as a triage tool, faecal calprotectin would have saved 10 of 30 microscopic colitis patients from undergoing colonoscopy.

Multivariate logistic regression analysis found that being diagnosed with microscopic colitis was significantly associated with having elevated faecal calprotectin levels (odds ratio [OR], 6, 95 percent confidence interval [CI], 2.2–16.3; p<0.001). The inverse was also true: elevated levels of faecal calprotectin significantly increased the risk of microscopic colitis (OR, 5.3, 95 percent CI, 2–14.1; p=0.001).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 3 days ago
Metabolic and bariatric surgery (MBS) leads to large and sustained reductions in, and even reversal of, multiple risk factors for future joint disease in adolescents with severe obesity and musculoskeletal pain, according to data from the Teen Longitudinal Assessment of Bariatric Surgery study.
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 6 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.